2756347-47-2
Chemical Structure
LC1236
- CAS No.: 2756347-47-2
- Formula:C21H16N2O5S
- Molecular Weight:408.43
InChIKey: MBXFRPFBHMRUCN-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=C(C(O)=O)C=C1)C(C2=CC=CC=C2)SC3=CC=C([N+]([O-])=O)C=C3
Biological Activity: LC1236 is a thymidylate synthase (hTS) dimer dissociator with a target Kd of 7 μM and poor transmembrane permeability. LC1236 inhibits enzymatic activity by shifting the monomer-dimer equilibrium toward inactive monomers. LC1236 acts as a cytotoxic agent to inhibit cancer cell growth, and exerts synergistic cytotoxicity with electroporation via enhancing intracellular accumulation. LC1236 can be used in the research of cancers such as ovarian cancer and colorectal cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LC1236 | LC1236 is a thymidylate synthase (hTS) dimer dissociator with a target Kd of 7 μM and poor transmembrane permeability. LC1236 inhibits enzymatic activity by shifting the monomer-dimer equilibrium toward inactive monomers. LC1236 acts as a cytotoxic agent to inhibit cancer cell growth, and exerts synergistic cytotoxicity with electroporation via enhancing intracellular accumulation. LC1236 can be used in the research of cancers such as ovarian cancer and colorectal cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
[1]. Marverti G, et al. Increased Ovarian and Colorectal Cancer Cell Sensitivity to Platinum Drugs and innovative TS Inhibitors by Electroporation. bioRxiv. 2026:2026-05.
- [2]. Costantino L, et al. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth. Elife. 2022;11:e73862. Published 2022 Dec 7. [Content Brief]
Keywords
